Previous studies have proposed that triple-negative breast cancer (TNBC) cells with a heightened interferon-stimulated gene signature are sensitive to ADAR1 gene silencing11–13 as are tumor cells with elevated levels of dsRNA species14,15. This evidence concerns the gene ADAR and neoplasm.